AKI

Acute Kidney Injury (AKI)

  • Definition: A term encompassing both slight deterioration and severe impairment of kidney function, characterized by rapid loss of kidney function.

  • Causes: Frequently due to hypertension, hypovolemia, or nephrotoxic agents. Common causes in the hospital include acute tubular necrosis (ATN) and prerenal causes.

Classification of AKI

  • Prerenal: External factors that reduce renal blood flow and decrease glomerular perfusion.

    • Factors include reduced circulation leading to decreased blood flow.

    • Body compensates by increasing blood volume through hormones (angiotensin II, aldosterone, norepinephrine, ADH).

    • May progress to intrarenal if not addressed.

  • Intrarenal (Intravenous): Direct damage to kidney tissue leading to impaired nephron function. Common causes include:

    • Prolonged ischemia

    • Nephrotoxins

    • Hemoglobin or myoglobin release from damaged cells (e.g., from trauma or necrosis).

    • Acute tubular necrosis is a common cause.

  • Postrenal: Obstruction of renal flow below the kidneys (accounting for ~10% of cases).

    • Common causes: Benign Prostatic Hyperplasia (BPH), prostate cancer, calculi, trauma, or tumors.

    • Bilateral ureter obstruction can lead to kidney necrosis.

    • Early intervention (e.g., removing the blockage within 48 hours) can lead to complete recovery.

Clinical Indicators of AKI

  • Diagnosis: Defined by an increase in serum creatinine and/or a reduction in urine output.

  • Oliguria: Reduction of urine output to less than 400 mL/day, can occur within 1-7 days after injury, especially in ischemia cases where it may happen within 24 hours.

  • Anuria: Urine output less than 50 mL/day, typically seen in complete bilateral obstructions.

  • Non-oliguric AKI: Common with ATN or intrarenal causes.

Stages of AKI

  1. Oliguric Phase: Decrease in urine output.

    • Many people (50%) do not experience this phase, but it is critical for prognosis.

    • Not solely indicative of AKI; further diagnostics needed.

  2. Diuretic Phase: Kidneys start to excrete waste, resulting in hypovolemia and electrolyte loss; urine cannot be concentrated.

  3. Recovery Phase: The timeline and quality depend on overall health, severity of AKI, and any complications.

Clinical Manifestations During Oliguric Phase

  • Fluid Volume: Retention leading to distension and potential pulmonary edema or heart failure.

  • Metabolic Acidosis: Inability to excrete hydrogen ions results in acid build-up and decreased bicarbonate.

  • Sodium and Potassium Imbalance: Damaged tubules cannot conserve sodium, leading to high levels in urine and potential hyperkalemia, a serious complication.

  • Waste Product Accumulation: Increased levels of urea, impacting metabolic functions.

  • Neurological Disorders: Fatigue, cognitive disturbances due to uremia.

Diagnostic Procedures

  • Urinalysis: May show casts, RBCs, WBCs, proteinuria, or abnormal electrolytes.

  • Imaging/Renal Biopsy: To identify underlying causes of AKI.

Dialysis Overview

  • Introduction to Dialysis: Used to remove waste products and excess fluid due to kidney failure.

  • Types of Dialysis:

    • Peritoneal Dialysis (PD): Involves infusing a dialysate solution into the peritoneum using a catheter.

      • Dwell Time: The period the solution remains in the abdomen to facilitate osmosis and diffusion.

      • Types of PD: Continuous ambulatory peritoneal dialysis (CAPD) and automated PD (APD).

      • Risks: Infection (peritonitis) and complications due to catheter placement.

    • Hemodialysis (HD): Blood is filtered externally using a dialyzer.

      • Requires vascular access (fistula or graft).

      • Typically performed three times a week for several hours.

      • Complications may include hypotension, muscle cramps, thrombosis, and infections.

    • Continuous Renal Replacement Therapy (CRRT): A slower method used for unstable patients, requiring special equipment.

      • Provides a more physiologic approach to filtering blood.

      • Nursing considerations include frequent hemofilter changes and careful monitoring.

Conclusion

  • Managing AKI and deciding on dialysis types involve assessing patient needs, symptoms, and underlying causes.

  • Education on treatment options and timely initiation of appropriate therapy is critical for patient outcomes.